Log in using OpenID

Dermatophytic Onychomycosis Treatment MarketDermatophytic Onychomycosis Treatment Market Growth Rate Analysis 2026

The global dermatophytic onychomycosis treatment market size was valued at US$ 2,596.8 million in 2017, and is expected to witness a CAGR of 12.6% over the forecast period 2018 – 2026.
Dermatophytic Onychomycosis Treatment
Market Size, Share, Trend, Outlook, Future
Growth Analysis And Synthesis 2018 - 2026
Dermatophytic onychomycosis, also known as tinea unguium, is a fungal disease of toenails or
fingernails that causes ring infection over nails. Trichophyton rubrum and trichophyton mentagrophytes
are common strains of fungi responsible for causing dermatophytic onychomycosis. Furthermore, yeasts
and non-dermatophyte molds are other agents that spread the infection. Public places such as gym,
swimming pool, and others that are infected with disease causing fungal agents are major source, which
cause dermatophytic onychomycosis. Moreover, continuous use of shoes for a longer duration and
contact of toe nail with wet surface causes the fungal infection. Increasing incidences of the infection
are evident in sportsperson, owing to continuous use of shoe, sweating at nails, and traumatic nail
Request Free Sample Copy @
Major symptoms of dermatophytic onychomycosis include thickening and whitening of nails. Moreover,
the nails become brittle and appear white as the infection progresses. People suffering from diabetes,
peripheral vascular disease, HIV, immune suppression, obesity, and geriatric population are at increased
risk of this common fungal infection. Dermatophytic onychomycosis could be treated with either topical
preparations or oral antifungal agents based on the severity of infection. The treatment often lasts for an
average period of six months. In recent past, advancement in therapy with the introduction of effective
topical and oral products has controlled the rapid spread of dermatophytic onychomycosis.
The global dermatophytic onychomycosis treatment market size was valued at US$ 2,596.8 million in
2017, and is expected to witness a CAGR of 12.6% over the forecast period (2018 – 2026).
Increased global prevalence of dermatophytic onychomycosis is expected to propel growth of the
dermatophytic onychomycosis treatment market
Dermatophytic onychomycosis is most common nail disorder. According to a report in the Journal of
Cutaneous Medicine and Surgery, 2017, onychomycosis accounts for 50% of all nail diseases and
prevalence of onychomycosis was estimated to be 5.5% with margin of error of + 3% worldwide.
Prophylactic use of topical antifungal agent is expected to aid in effective treatment of dermatophytic
onychomycosis, which in turn is major factor contributing to the market growth.
Development of new therapies that aid in treatment of dermatophytic onychomycosis is expected to drive
growth of the dermatophytic onychomycosis treatment market over the forecast period
Introduction of new drug candidates and adoption of new treatment approaches is a major factor
contributing to the dermatophytic onychomycosis treatment market growth. For instance, in 2014, the
U.S. Food and Drug Administration (FDA) approved two new topical antifungal drugs—efinaconazole and
tavaborole— for the treatment of dermatophytic onychomycosis caused by Trichophyton rubrum and
Trichophyton mentagrophytes. Efinaconazole is the first approved topical triazole antifungal agent and
tavaborole is the first approved oxobarole antifungal agent for this indication. These agents offer short
treatment courses, high cure rates, and few relapse cases.
Report includes chapters which deeply display the following deliverable about industry :
• Dermatophytic Onychomycosis Treatment Market Research Objective and Assumption
• Dermatophytic Onychomycosis Treatment Market Purview - Report Description, Executive
Summary, and Coherent Opportunity Map (COM)
• Dermatophytic Onychomycosis Treatment Market Dynamics, Regulations, and Trends Analysis Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Dermatophytic Onychomycosis Treatment Market, By Regions
• Dermatophytic Onychomycosis Treatment Market Competition by Manufacturers including
Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and
Product Type.
• Dermatophytic Onychomycosis Treatment Market Manufacturers Profiles/Analysis including
Company Basic Information, Manufacturing Base and Its Competitors.
• Dermatophytic Onychomycosis Treatment Market Manufacturing Cost Analysis including Key
Raw Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Dermatophytic Onychomycosis Treatment Market Forecast including Production, Consumption,
Import and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Global Dermatophytic Onychomycosis Treatment Market Key Players
Key players operating in the dermatophytic onychomycosis treatment market include, Bausch Health
Companies, Galderma S.A., Celtic Pharma, Anacor pharmaceuticals, Inc., Johnson & Johnson, Novartis
AG, Pfizer Inc., GlaxoSmithKline, Topica Pharmaceuticals, Inc., Moberg Pharma AB, Bayer AG, Dr.
Reddy’s Laboratories Ltd, Allergen, Inc., Cipla Ltd, Medimetriks Pharmaceuticals Inc., Sanofi S.A.,
NovaBiotics Inc., and Merz Pharma.
Detailed Segmentation:
Global Dermatophytic Onychomycosis Treatment Market, By Therapy Type:
Systemic Therapy
Topical Therapy
Device-based Therapy
Global Dermatophytic Onychomycosis Treatment Market, By End User:
Dermatology Clinics
Retail Pharmacies
Global Dermatophytic Onychomycosis Treatment Market, By Geography:
North America
Latin America
Asia Pacific
Middle East
Get Full Access of This Business Report:
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Poul Master
Poul Master247   documents Email
Health and Medicine
File Size
121 KB
dermatophytic onychomycosis treatment market size, treatment
Report inappropriate content